Defining a National AIDS Policy Panel

AIDS (Disease); AIDS (Disease)--Political aspects--United States; ACT UP (Organization); New York (State)--New York; United States; AIDS (Disease)--History; AIDS (Disease)--Social aspects--United States; Clinical trials--Reporting; Clinical drug trials; Drugs--Testing; Clinical trials of drugs; Drug bioscreening ; Drug trials ; Drugs--Clinical trials; Drugs--Effectiveness--Testing; Drugs--Evaluation; AIDS (Disease) in women

NIH-moderated panel about defining a national AIDS policy, research health services, and prevention in four talks from Maxine Wolfe (ACT UP), Dr. Wanda Jones (CDC), Corola Marta (Yale physician), and community activist Michelle Lopez.

[Julie Auerbach] Coordinator of the Behavioral and Social Science activities in the office of AIDS research at the National Institute of Health moderates a panel that discusses defining a national AIDS policy, research health services, and prevention in four talks. The panel begins with ACT UP activist Maxine Wolfe, followed by Dr. Wanda [Johns/Jones], the Associate Director for Women's Health at the Center for Disease Control. Side B continues with Dr. Wanda [Johns/Jones], followed by [Corola] Marta, a physician with the Yale AIDS program whose work was focused on inner-city primary care and women's health. The recording cuts off the last talk from community activist Michelle Lopez involved in issues related to women and children in New York. Lopez was also on the board that planned the conference.

Donated by Maxine Wolfe on 1993-07-26

Undated

Digitized on 2015-10-15 and 2015-10-22

Processed by Pratt School of Information LIS-668 students, Fall 2015

See the LHA Rights page for more information

English

Audio cassette

SPW1686_DefiningNationalAidsPolicy

00:46:33